News and Press Releases July 31, 2008   JT Reports Consolidated Financial Results for the First Quarter that Ended June 30, 2008 May 1, 2008   JT Reports Consolidated Financial Results For the Full Fiscal Year that Ended March 31, 2008 February 7, 2008   JT Reports Consolidated Financial Results For the Nine-Month Period that Ended December 31, 2007 October 31, 2007   JT Reports Consolidated Financial Results for the First Fiscal Half that Ended September 30, 2007 September 26, 2007   JT and Torii Sign Licensing Agreement with Keryx for Development and Commercialization of Hyperphosphatemia Drug in Japan August 9, 2007   JT Announces its First-Quarter Consolidated Financial Results and Gallaher Integration Plan(PDF file) April 27, 2007   JT Reports Consolidated Financial Results for the Full Fiscal Year that Ended March 31, 2007(PDF file) February 8, 2007   JT Reports Consolidated Financial Results for the Nine-Month Period that Ended December 31, 2006 (PDF file) December 28, 2006   JT Announces Licensing Agreement for New Antibody Drug Candidate with MedImmune November 28, 2006   New Drug Application of Antipruritic Agent "TRK-820" for the Treatment of Severe Pruritus in Hemodialysis Patients in Japan October 31, 2006   JT Reports Consolidated Interim Financial Results For the First Fiscal Half that Ended September 30, 2006(PDF file) July 31, 2006   JT Reports Consolidated Financial Results for the First Quarter that Ended June 30, 2006(PDF file) April 28, 2006   JT Reports Consolidated Financial Results for the Full Fiscal Year that Ended March 31, 2006(PDF file) April 18, 2006   JT Concludes Licensing Agreement for a New Drug Candidate with GlaxoSmithKline February 17, 2006   JT Reports Consolidated Financial Results for the Nine Month Period That Ended December 31, 2005(PDF file) October 31, 2005   JT Reports Consolidated Interim Financial Results For the First Fiscal Half That Ended September 30, 2005(PDF file) August 1, 2005   JT Reports Consolidated Financial Results for the First Quarter that Ended June 30, 2005 (PDF file) April 27, 2005   JT Reports Consolidated Financial Results for the Fiscal Year that Ended March, 2005 (PDF file) April 22, 2005   JT Group to Merge Pharmaceutical Production Facilities April 8, 2005   JT and Torii Pharmaceutical to Launch New HIV Treatment Drugs in Japan March 22, 2005   JT Concludes License Agreement on JT's Anti-HIV drug with Gilead March 16, 2005   Toray, JT, Torii Pharmaceutical Agree Co-development and Marketing February 17, 2005   JT's consolidated Financial Results for the Nine-Month Period that Ended December 31, 2004 (PDF file) October 29, 2004   JT's consolidated Interim Results for the First Half that Ended September 30, 2004 (PDF file) October 24, 2004   JT and Roche Conclude Licensing Agreement on JT's Dyslipidemia Compound ©2007 Akros Pharma Inc. All rights reserved.